Publicacións nas que colabora con Lorena de la Fuente Tomás (25)

2022

  1. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 1, pp. 22-28

  2. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 1, pp. 14-21

2021

  1. Are older adults also at higher psychological risk from COVID-19?

    Aging and Mental Health, Vol. 25, Núm. 7, pp. 1297-1304

  2. Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain

    Addictive Behaviors, Vol. 121

  3. Impact of the coronavirus outbreak on mental health in the different Spanish regions

    Actas espanolas de psiquiatria, Vol. 49, Núm. 2, pp. 64-70

  4. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia

    Psicothema, Vol. 33, Núm. 3, pp. 473-480

2020

  1. COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?

    Schizophrenia Research, Vol. 223, pp. 192-198

  2. Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

    Scientific Reports, Vol. 10, Núm. 1

  3. Early Psychological Correlates Associated With COVID-19 in A Spanish Older Adult Sample

    American Journal of Geriatric Psychiatry, Vol. 28, Núm. 12, pp. 1287-1298

  4. Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample

    Journal of global health, Vol. 10, Núm. 2, pp. 020505

  5. Prevalence of Passive Suicidal Ideation in the Early Stage of the Coronavirus Disease 2019 (COVID-19) Pandemic and Lockdown in a Large Spanish Sample

    The Journal of clinical psychiatry, Vol. 81, Núm. 6

  6. Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts

    European Neuropsychopharmacology, Vol. 40, pp. 17-30

  7. Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene

    Schizophrenia Research

  8. ¿Se observarán cambios en el consumo de alcohol y tabaco durante el confinamiento por COVID-19?

    Adicciones: Revista de socidrogalcohol, Vol. 32, Núm. 2, pp. 85-89

2019

  1. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 9-16

  2. Clinical staging in severe mental disorders; bipolar disorder, depression and schizophrenia

    Revista de Psiquiatria y Salud Mental

  3. Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 116-129

  4. Early versus late stage schizophrenia. What markers make the difference?

    World Journal of Biological Psychiatry, Vol. 20, Núm. 2, pp. 159-165

  5. Factores asociados con consumo de tabaco en pacientes con depresión

    Adicciones: Revista de socidrogalcohol, Vol. 31, Núm. 4, pp. 298-308

  6. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794